---
figid: PMC6938856__gr10
figlink: pmc/articles/PMC6938856/figure/fig10/
number: Figure 10
caption: Illustration of the Regulatory Mechanism of Silencing lncRNA RP1-93H18.6
  in CCSilencing lncRNA RP1-93H18.6 can inhibit the progression of CC by inhibiting
  HeLa cell proliferation and EMT while promoting cell apoptosis through inactivation
  of the PI3K/Akt/mTOR signaling pathway. CC, cervical cancer; lncRNA, long non-coding
  RNA; EMT, epithelial-mesenchymal transition; PI3K, phosphatidylinositol-3-kinase;
  Akt, serine/threonine kinase; mTOR, mammalian target of rapamycin.
pmcid: PMC6938856
papertitle: Silencing of Long Non-coding RNA RP1-93H18.6 Acts as a Tumor Suppressor
  in Cervical Cancer through the Blockade of the PI3K/Akt Axis.
reftext: Qian Wang, et al. Mol Ther Nucleic Acids. 2020 Mar 6;19:304-317.
pmc_ranked_result_index: '1270'
pathway_score: 0.9689938
filename: gr10.jpg
figtitle: Silencing of Long Non-coding RNA RP1-93H18.6 Acts as a Tumor Suppressor
  in Cervical Cancer through the Blockade of the PI3K/Akt Axis
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6938856__gr10.html
  '@type': Dataset
  description: Illustration of the Regulatory Mechanism of Silencing lncRNA RP1-93H18.6
    in CCSilencing lncRNA RP1-93H18.6 can inhibit the progression of CC by inhibiting
    HeLa cell proliferation and EMT while promoting cell apoptosis through inactivation
    of the PI3K/Akt/mTOR signaling pathway. CC, cervical cancer; lncRNA, long non-coding
    RNA; EMT, epithelial-mesenchymal transition; PI3K, phosphatidylinositol-3-kinase;
    Akt, serine/threonine kinase; mTOR, mammalian target of rapamycin.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - CDH1
  - BCL2
  - AKT2
  - AKT3
  - AKT1
  - MTOR
  - BAX
  - LY294002
  - carcinoma
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: E-cadherin
  symbol: CDH1
  source: hgnc_symbol
  hgnc_symbol: CDH1
  entrez: '999'
- word: Bcl-2
  symbol: Bcl-2
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: ΑΚΤ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: ΑΚΤ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: ΑΚΤ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Вах
  symbol: BAX
  source: hgnc_symbol
  hgnc_symbol: BAX
  entrez: '581'
chemicals:
- word: LY294002
  source: MESH
  identifier: C085911
diseases:
- word: carcinoma
  source: MESH
  identifier: D002277
---
